Article Versions Notes

Chan C-Y, Hong S-C, Chang C-M, Chen Y-H, Liao P-C, Huang C-Y. Oral Squamous Cell Carcinoma Cells with Acquired Resistance to Erlotinib Are Sensitive to Anti-Cancer Effect of Quercetin via Pyruvate Kinase M2 (PKM2). Cells. 2023; 12(1):179. https://doi.org/10.3390/cells12010179

Chan, Chien-Yi, Shih-Cing Hong, Chin-Ming Chang, Yuan-Hong Chen, Pin-Chen Liao, and Chun-Yin Huang. 2023. "Oral Squamous Cell Carcinoma Cells with Acquired Resistance to Erlotinib Are Sensitive to Anti-Cancer Effect of Quercetin via Pyruvate Kinase M2 (PKM2)" Cells 12, no. 1: 179. https://doi.org/10.3390/cells12010179

Chan, C.-Y., Hong, S.-C., Chang, C.-M., Chen, Y.-H., Liao, P.-C., & Huang, C.-Y. (2023). Oral Squamous Cell Carcinoma Cells with Acquired Resistance to Erlotinib Are Sensitive to Anti-Cancer Effect of Quercetin via Pyruvate Kinase M2 (PKM2). Cells, 12(1), 179. https://doi.org/10.3390/cells12010179